Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
By LabMedica International staff writers Posted on 28 Jul 2015 |
In an oral poster presentation of the “Endocrinology in Preventive and Chronic Care” session at AACC 2015 (July 26-30; Atlanta, GA, USA), researchers presented and discussed results of a study suggesting that simple, noninvasive testing of hair samples may offer new insights into the relationship between asthma, levels of the stress-hormone cortisol, and related complications in pregnancy.
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Latest AACC 2015 News
- Automated Molecular Diagnostics System Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear
Parkinson’s disease is notoriously difficult to diagnose in its early stages, as motor symptoms do not appear until later in the progression of the disease. The ability to detect the disease up to seven... Read more
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis
Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more
New Gene Tool to Enable Earlier Detection and Treatment of Cardiometabolic Diseases
Cardiometabolic diseases, which affect the heart, blood vessels, and the body's ability to process food and generate energy, are difficult to diagnose early due to the complex genetic changes that contribute... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy
To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read moreMicrobiology
view channel
Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
Cardiovascular disease is the leading cause of death worldwide, and atherosclerosis plays a critical role in its development. This chronic condition, characterized by the hardening and narrowing of arteries... Read more
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Tool Accurately Determines Breast Cancer Prognosis
A new study has found that cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to treatment. The research, published in the journal Patterns,... Read more
Powerful New Tool Improves Tissue Cancer Analysis
Studying the mix of cell types in human tissue is crucial for understanding diseases like cancer, but it presents significant challenges in both accuracy and scalability. The tumor microenvironment, composed... Read moreTechnology
view channel
Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells
A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Safer, Portable and Low-Cost Imaging Solution to Revolutionize Biomedical Diagnostics
In diagnosing diseases and monitoring treatment, accurate and quick detection of temperature within biological tissues can be crucial, especially in early disease detection. Conventional methods such as... Read more
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read moreIndustry
view channel
QuidelOrtho and BÜHLMANN Collaborate on Gastrointestinal Biomarker Tests
QuidelOrtho Corporation (San Diego, CA, USA) and BÜHLMANN Laboratories AG (Schönenbuch, Switzerland) have announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's... Read more